Two Telehealth Executives Sentenced for Scheme to Distribute Adderall 

Two executives of a telehealth company focused on treating attention deficit hyperactivity disorder have been sentenced to prison after the start-up organized a scheme to illegally distribute more than 37 million pills of the stimulant Adderall. The Department of Justice announced on Tuesday that Ruthia He, the founder and former chief executive of the company,…

Read More

US appeals court revives hundreds of private lawsuits linking Tylenol to autism 

NEW YORK, July 13 (Reuters) – A federal appeals court on Monday revived more than 500 private lawsuits against Tylenol maker Kenvue (KVUE.N), opens new tab over ‌the painkiller’s alleged link to autism. The 2nd U.S. Circuit Court of Appeals in Manhattan said a district court judge improperly excluded expert testimony from three doctors offered…

Read More

Is It Time to Move Beyond the DSM? Dispatches From the 2026 APA Annual Meeting — Part 2 (Commentary)

Key Points: DSM validity criticized; psychiatry should mirror other specialties’ research-based diagnoses. False DSM phenotypes may obscure true biomarkers/genetic signals in depression research. Current DSM structure may perpetuate outdated, weakly validated diagnoses incl MDD, ADHD, some personality disorders. Incremental DSM-5 revision may be insufficient if core diagnostic structure remains unchanged. ICD already supports coding; DSM…

Read More

Broad neurodevelopmental spectrum better predicts children’s educational outcomes

A paper published in the leading journal Molecular Psychiatry on Friday 3 July at 1am British Summer time led by researchers from Queen Mary University of London and Royal Holloway, University of London challenges the way we think about neurodevelopmental conditions. The study suggests it would be better for experts to focus on a broad constellation…

Read More